FDA Approves Leqembi: What You Should Know

Send us a text FDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes? Dive deeper into this episode and read our report, Leqembi: What to Know About the New Alzheimer's Drug. https://www.caretalkpodcast.com/post/leqembi-what-to-know-about-the-new-alzheimer-s-drug ABOUT CARETALK CareTalk is a weekly podcast that provides a...